About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials | 951 Studies Recruiting

Clinical TrialsBrain Cancer

Brain Cancer Clinical Trials

Browse 951 clinical trials for brain cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 201-220 of 951 trials

CompletedCediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent GlioblastomaThis phase I trial is studying the side effects and best dose of cediranib maleate when given together with cilengitide in treating patients with progressive or recurrent…NCT00979862·Birmingham, Alabama and 10 others TerminatedMethylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain TumorsRATIONALE: Methylphenidate may decrease side effects of radiation therapy.NCT00031798·Phoenix, Arizona and 6 others

Related Searches

glioblastomatrials gliomatrials brain tumortrials

Data from ClinicalTrials.govTerms

UnknownSafety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant GliomaThe purpose of this study is to evaluate the safety and biologically active dose of TM-601 in adult patients with recurrent malignant glioma.NCT00591058·Birmingham, Alabama and 6 others

TerminatedPhase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent GlioblastomaThe goal of Part I of this clinical research study is to find the highest tolerable dose of TPI 287 that can be given with bevacizumab to patients with glioblastoma.NCT01582152·Houston, Texas

CompletedAssessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) DisruptionThe purpose of this study is to evaluate the safety of the ExAblate Model 4000 Type 2 used as a tool to disrupt the BBB (blood brain barrier) in patients with high grade glioma…NCT03551249·Baltimore, Maryland and 3 others

CompletedValproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS TumorsRATIONALE: Drugs used in chemotherapy, such as valproic acid, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from…NCT00107458·Orange, California and 16 others

Active not recruitingLonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with TemozolomideThis phase I trial studies the side effects and best dose of lonafarnib when given together with temozolomide and to see how well they work in treating patients with glioblastoma…NCT00102648·Houston, Texas

RecruitingCharacterization of the Blood-Brain Barrier in High-Grade Glioma Through Immunohistochemical, Transcriptional, Fluorescein and Radiological AnalysesThis prospective study aims to characterize blood brain barrier (BBB) disruption in patients with newly diagnosed glioblastoma multiforme undergoing surgical resection.NCT07731555·Beaumont

Active not recruitingVorinostat and Temozolomide in Treating Patients With Malignant GliomasThis phase I trial is studying the side effects and best dose of vorinostat when given together with temozolomide in treating patients with malignant gliomas.NCT00268385·Birmingham, Alabama and 16 others

TerminatedDasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsRATIONALE: Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00788125·Duarte, California

CompletedBorder Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma MultiformeThis is a phase II study on the usage of stereotactic Gamma Knife radiosurgery as a boost to the tumor bed border zone in conjunction with the usage of bevacizumab.NCT02120287·Pittsburgh, Pennsylvania

CompletedChemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by SurgeryRATIONALE: Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from…NCT00626015·Durham, North Carolina

RecruitingPharmacoscopy for Patients With Refractory Primary Brain TumorsAdvanced technology of ex vivo drug profiling referred to as pharmacoscopy may allow to identify novel drugs for the treatment of glioblastoma and other refractory brain tumors at…NCT06804655·Basel, Basel-Landschaft and 2 others

Active not recruitingClinical Significance of Liquid Biopsy in Brain Tumor Patients: a 5-ALA Guided ApproachGlioblastoma (GBM) is the most common and lethal primary brain tumor.NCT07420543·Milan

CompletedAntineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma MultiformeRATIONALE: Current therapies for Glioblastoma Multiforme provide very limited benefit to the patient.NCT00003474·Houston, Texas

TerminatedAspirin Prophylaxis for Venous Thromboembolism in GlioblastomaPrimary objective: To determine whether aspirin (ASA) can lower the incidence of Venous Thromboembolism(VTE) in patients with Glioblastoma (GBM).NCT00790452·Houston, Texas

CompletedSafety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain TumorsImmunotoxin therapy may be effective in treating malignant glioma. Immunotoxins can locate tumor cells and kill them without harming normal cells.NCT00104091

CompletedVorinostat in Treating Patients With Progressive or Recurrent Glioblastoma MultiformeThis phase II trial is studying how well vorinostat works in treating patients with progressive or recurrent glioblastoma multiforme.NCT00238303·Rochester, Minnesota

WithdrawnFunctional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain TumorsRATIONALE: New imaging procedures, such as functional magnetic resonance imaging and 1H-nuclear magnetic resonance spectroscopic imaging, may improve the ability to detect the…NCT00005083

TerminatedAssessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and WaterPurpose of Study This exploratory clinical study will investigate FMISO (fluoromisonidazole) in patients with (1) newly diagnosed primary malignant brain tumors (WHO \[World…NCT01246869·Salt Lake City, Utah

PreviousPage 11 of 48Next